Analysis of colorectal cancer outcomes for the Australian National Bowel Cancer Screening Program

Asia-Pacific Journal of Clinical Oncology

Volumn 12, Issue 1, 2016, Pages 22-32

 

^a Australian Dept of Health/Ageing   (Australia)

^b NATIONAL HEALTH AND MEDICAL RESEARCH COUNCIL   (Australia)

Author keywords

Australia; Cancer staging; Colorectal cancer; Mortality; Screening

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; AUSTRALIA; AUSTRALIAN; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER MORPHOLOGY; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CANCER STAGING; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; EARLY DIAGNOSIS; FEMALE; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORBIDITY; OCCULT BLOOD TEST; ONSET AGE; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGRAM EFFECTIVENESS; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; COLORECTAL NEOPLASMS; EARLY CANCER DIAGNOSIS; INCIDENCE; PROCEDURES;

AUSTRALIA; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED;

EID: 84958019758     PISSN: 17437555     EISSN: 17437563     Source Type: Journal    
DOI: 10.1111/ajco.12452     Document Type: Article

References (24)

1. Australian Institute of Health and Welfare. Cancer in Australia: an overview, 2014. Cancer series no. 90. Cat. no. CAN 88. Australian Institute of Health and Welfare, Canberra 2014.
2. Kewenter J, Brevinge H, Engaras B, Haglind E, Ahren C. Results of screening, rescreening, and follow-up in a prospective randomized study for detection of colorectal cancer by fecal occult blood testing. Results for 68, 308 subjects. Scand J Gastroenterol 1994; 29: 468-73.
3. Hardcastle JD, Chamberlain JO, Robinson MHE et al. Randomised controlled trial of faecal occult blood screening for colorectal cancer. Lancet 1996; 348: 1472-7.
4. Kronberg O, Fenger C, Olsen J, Jorgenson OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996; 348: 1467-71.
5. Mandel JS, Church TR, Ederer F, Bond JH. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst 1999; 91(5): 434-7.
6. Towler BP, Irwig L, Glasziou P, Weller D, Kewenter J. Screening for colorectal cancer using the faecal occult blood test, Hemoccult. Cochrane database of Systematic Reviews 1998; Issue 2, Art. No. CD001216. doi: 10.1002/14651858.CD001216.
7. Australian Institute of Health and Welfare. Analysis of bowel cancer outcomes for the National Bowel Cancer Screening Program. Cat. no. CAN 87. Australian Institute of Health and Welfare, Canberra 2014.
8. International Agency for Research on Cancer. International rules for multiple primary cancers (ICD-O Third Edition). International Agency for Research on Cancer, Lyon 2004. [Cited 4 Feb 2014]. Available from http://www.iacr.com.fr/MPrules_july2004.pdf.
9. Cancer Council Australia and Australian Cancer Network. Clinical practice guidelines for the prevention, early detection and management of colorectal cancer. Cancer Council Australia and Australian Cancer Network, Sydney 2005. [Cited 3 Feb 2014]. Available from http://www.nhmrc.gov.au/guidelines-publications/cp106.
10. Brenner H, Altenhofen L, Katalinic A, Lansdorp-Vogelaar I, Hoffmeister M. Sojourn time of preclinical colorectal cancer by sex and age: estimates from the German National Screening Colonoscopy Database. Am J Epidemiol 2011; 174(10): 1140-6.
11. Duffy SW, Nagtegaal ID, Wallis M et al. Correcting for lead time and length bias in estimating the effect of screen detection on cancer survival. Am J Epidemiol 2008; 168(1): 98-104.
12. Day NE, Walter SD. Simplified models of screening for chronic disease: estimation procedures from mass screening programmes. Biometrics 1984; 40: 1-14.
13. Walter SD, Stitt LW. Evaluating the survival of cancer cases detected by screening. Stat Med 1987; 6: 885-900.
14. Cole SR, Tucker GR, Osborne JM et al. Shift to earlier stage at diagnosis as a consequence of the National Bowel Cancer Screening Program. Med J Aust 2013; 198(6): 327-30.
15. Australian Institute of Health and Welfare. National Bowel Cancer Screening Program monitoring report: 2012-13. Cancer series no. 84. Cat. no. CAN 81. Australian Institute of Health and Welfare, Canberra 2014.
16. Ananda SS, McLaughlin SJ, Chen F et al. Initial impact of Australia's National Bowel Cancer Screening Program. Med J Aust 2009; 191(7): 378-81.
17. Steele RJ, McClements P, Watling C et al. Interval cancers in a FOBT-based colorectal cancer population screening programme: implications for stage, gender and tumour site. Gut 2012; 61(4):576-81.
18. Morris M, Lacopetta B, Platell C. Comparing survival outcomes for patients with colorectal cancer treated in public and private hospitals. Med J Aust 2007; 186(6): 296-300.
19. Wray CM, Ziogas A, Hinojosa MW, Le H, Stamos MJ, Zell JA. Tumor subsite location within the colon is prognostic for survival after colon cancer diagnosis. Dis Colon Rectum 2009; 52(8): 1359-66.
20. Gonzalez EC, Roetzheim RG, Ferrante JM, Campbell R. Predictors of proximal vs. distal colorectal cancers. Dis Colon Rectum 2001; 44: 251-8.
21. Haug U, Kuntz KM, Knudsen AB, Hundt S, Brenner H. Sensitivity of immunochemical faecal occult blood testing for detecting left- vs right-sided colorectal neoplasia. Br J Cancer 2011; 104: 1779-85.
22. Levi Z, Rozen P, Hazazi R et al. A quantitative immunochemical fecal occult blood test for colorectal neoplasia. Ann Intern Med 2007; 146(4): 244-55.
23. Burch JA, Soares-Weiser K, St John DJB, Duffy S, Smith S, Kleijnen J, Westwood M. Diagnostic accuracy of faecal occult blood tests used in screening for colorectal cancer: a systematic review. J Med Screen 2007; 14: 132-7.
24. Shin A, Choi KS, Jun JK et al. Validity of fecal occult blood test in the national cancer screening program, Korea. Public Library of Science One 2013; 8(11): e79292. doi: 10.1371/journal.pone.0079292.